Drug Profile
Pramipexole/rasagiline - Pharma Two B
Alternative Names: P2B-001; Rasagaline/pramipexoleLatest Information Update: 20 Nov 2023
Price :
$50
*
At a glance
- Originator Pharma Two B
- Class Antiparkinsonians; Benzothiazoles; Indans; Small molecules
- Mechanism of Action Dopamine D2 receptor agonists; Dopamine D3 receptor agonists; Monoamine oxidase B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Parkinson's disease
Most Recent Events
- 14 Nov 2023 Updated adverse events data from a phase III trial in Parkinson's-disease released by Pharma Two B
- 28 Aug 2023 Efficacy data from a phase III trial in Parkinson's Disease released by Pharma Two B
- 23 Apr 2023 Phase III development is completed recently for Parkinson's disease in Canada, Germany and Spain (PO)